Invasive apergillosis with myocardial involvement after kidney transplantation
Open Access
- 25 February 2005
- journal article
- case report
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 20 (3) , 631-634
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and NeutropeniaNew England Journal of Medicine, 2004
- Antifungal attributes of immunosuppressive agents: new paradigms in management and elucidating the pathophysiologic basis of opportunistic mycoses in organ transplant recipients1Transplantation, 2004
- Invasive aspergillosis in solid-organ transplantation: report of eight cases and review of the literatureTransplant International, 2003
- Voriconazole versus Amphotericin B for Primary Therapy of Invasive AspergillosisNew England Journal of Medicine, 2002
- Aspergillosis Case-Fatality Rate: Systematic Review of the LiteratureClinical Infectious Diseases, 2001
- Aspergillus fumigatus and AspergillosisClinical Microbiology Reviews, 1999
- Invasive Aspergillosis in Transplant RecipientsMedicine, 1999
- Invasive Aspergillosis in Mice Immunosuppressed with Cyclosporin A, Tacrolimus (FK506), or Sirolimus (Rapamycin)The Journal of Infectious Diseases, 1997
- A RANDOMIZED PROSPECTIVE TRIAL OF PROPHYLACTIC IMMUNOSUPPRESSION WITH ATG-FRESENIUS VERSUS OKT3 AFTER RENAL TRANSPLANTATIONTransplantation, 1995
- Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biologyCurrent Opinion in Immunology, 1993